echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Phytomedicine: Yiqi Fumai for injection (freeze-dried) reduces cerebral ischemic damage by inhibiting neuronal autophagy

    Phytomedicine: Yiqi Fumai for injection (freeze-dried) reduces cerebral ischemic damage by inhibiting neuronal autophagy

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Background: Yiqi Fumai freeze-dried injection (YQFM) is derived from the classic ancient prescription Shengmai San , composed of red ginseng, Ophiopogon japonicus and Schisandra chinensis , and is clinically used in the treatment of cardiovascular and cerebrovascular diseases
    .


    ATG9A is the only transmembrane protein responsible for transporting membrane components to autophagosomes.


    Yiqi Fumai Freeze-dried Injection (YQFM) Yiqi Fumai Freeze-dried Injection (YQFM) Red Ginseng, Ophiopogon and Schisandra 3 Chinese Medicine Red Ginseng, Ophiopogon and Schisandra 3 Chinese Medicine Cardiovascular and Cerebrovascular Diseases Cardiovascular and Cerebrovascular Diseases ATG9A ATG9A NMMHC IIA NMMHC IIA oxygen-glucose deprivation and reoxidation (OGD/R) oxygen-glucose deprivation and reoxidation (OGD/R)

    Objective: To evaluate whether YQFM can form autophagosomes by inhibiting the interaction of NMMHC IIA-actin-ATG9A, which has a neuroprotective effect on cerebral ischemia-reperfusion injury
    .

    Methods: The neurological deficit, infarct volume and histopathological changes of middle cerebral artery occlusion/reperfusion (MCAO/R) mice were detected to observe the protective effect of YQFM on brain nerves .
    NMMHC IIA-actin-ATG9A by interaction colocalization immunofluorescence , immunoprecipitation determined .
    In vitro experiments used rat pheochromocytoma (PC12) cells to simulate neurons after oxygen-glucose deprivation/reoxidation (OGD/R) .

    Middle cerebral artery occlusion/reperfusion (MCAO/R) mouse Middle cerebral artery occlusion/reperfusion (MCAO/R) mouse neurological deficit, infarct volume and histopathology Neurological deficit, infarct volume and histopathology immunofluorescence colocalization immunofluorescence colocalization immunoprecipitation immunoprecipitation analog neuron analog neuron

    Results: The neuroprotection of different doses of YQFM (0.


    336, 0.
    671, 1.
    342 g/kg) and positive control drug nimodipine (5 mg/kg) on ​​MCAO mice was evaluated by the area of ​​infarct area and the score of neurological deficit 24h after reperfusion.


    Histopathology, morphology, and neurological deficit scores indicate that YQFM has neuroprotective effects on MCAO/R mice, which may be related to autophagy
    .


    Western blotting results of autophagy-specific marker proteins p62 and LC3B showed that MCAO/R damage was reduced after YQFM treatment


    The results of immunofluorescence staining showed that YQFM can significantly inhibit the translocation of ATG9A induced by MCAO/R and play a protective role
    .


    Fluorescence colocalization results show that YQFM regulates the interaction of NMMHC IIA-F-actin-ATG9A, inhibits ATG9A translocation in MCAO/R mice, and reduces cerebral ischemia/reperfusion injury


    Immunofluorescence staining immunofluorescence staining

    Using PC12 cells to simulate neurons in vitro, the results show that YQFM (400 μg/ml) can significantly inhibit OGD/R-induced excessive autophagy in PC12 cells by interfering with the translocation of ATG9A
    .


    In addition, the RNAi of NMMHC IIA attenuates the NMMHC IIA-F-actin-mediated ATG9A transport, thereby weakening the in vitro neuroprotective activity of YQFM


    Conclusion: YQFM inhibits excessive autophagy and exerts neuroprotective effects by interfering with NMMHC IIA-actin-mediated ATG9A translocation .
    It is a promising drug for the treatment of brain I/R injury
    .


    The results of this study provide experimental evidence for YQFM to prevent and treat brain I/R, but the importance of various components in YQFM is still unclear, and further research is needed


    Inhibition of excessive autophagy Inhibition of excessive autophagy

    Literature source:

    Literature source:

    Su, L.


    Su, L.
    , Liu, Y.
    , Ma, H.
    , et al.
    (2021).
    YiQiFuMai lyophilized injection attenuates cerebral ischemic injury with inhibition of neuronal autophagy through intervention in the NMMHC IIA-actin-ATG9A interaction.
    Phytomedicine: international journal of phytotherapy and phytopharmacology, 95, 153882.
    Advance online publication.
    https://doi.
    org/10.
    1016/j.
    phymed.
    2021.
    153882 Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.